12 August 2024: The Board of Directors (“Board”) hereby calls for an Extraordinary General Meeting of Aker BioMarine ASA (the “Company”) at 10.00 CET on 3 September 2024.
Reference is made to stock exchange notification sent by the Company on July 3rd, 2024. In order to execute payment of dividend as planned, the Board proposes that the general meeting, on the basis of the approved annual accounts for 2023, authorizes the Board to resolve distribution of dividends. The authorization shall be valid until 31 December 2024.
The General Meeting will be held as a digital event. Link for the meeting and further information regarding participation is available at the Company’s website www.akerbiomarine.com/EGM.
No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Proxy, proxy with voting instructions or advance votes are asked to be sent in by 30
August 2024 at 4:00 pm.
The notice and proxy forms for the Extraordinary General Meeting is attached.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.